30479064 22162439 28548958 26481614 23372742 28349833 24204677 33573284 34790130 25351849 36182709 25292079 28732081 24446297 29692379 21848890 32711026 21871937 23533647 21751957 26005639 33803434 36529349 24886605 20332318 22677780 26198920 2395121 - Search Results

Year	Number of Results
2010	1
2011	6
2012	3
2013	4
2014	5
2015	3
2017	3
2018	3
2019	1
2020	1
2021	3
2022	2
2023	2

1

The challenge of defining "ultra-high-risk" neuroblastoma.

Morgenstern DA, Bagatell R, Cohn SL, Hogarty MD, Maris JM, Moreno L, Park JR, Pearson AD, Schleiermacher G, Valteau-Couanet D, London WB, Irwin MS. Morgenstern DA, et al. Pediatr Blood Cancer. 2019 Apr;66(4):e27556. doi: 10.1002/pbc.27556. Epub 2018 Nov 26. Pediatr Blood Cancer. 2019. PMID: 30479064 Review.

2

Inflammation: what role in pediatric cancer?

Morgenstern DA, Anderson J. Morgenstern DA, et al. Pediatr Blood Cancer. 2012 May;58(5):659-64. doi: 10.1002/pbc.24008. Epub 2011 Dec 11. Pediatr Blood Cancer. 2012. PMID: 22162439 Review.

3

Interleukin-6-174G>C gene promoter polymorphism and prognosis in patients with cancer.

Zhai K, Yang Y, Gao ZG, Ding J. Zhai K, et al. Oncotarget. 2017 Jul 4;8(27):44490-44497. doi: 10.18632/oncotarget.17771. Oncotarget. 2017. PMID: 28548958 Free PMC article.

4

Association study of functional polymorphisms in interleukins and interleukin receptors genes: IL1A, IL1B, IL1RN, IL6, IL6R, IL10, IL10RA and TGFB1 in schizophrenia in Polish population.

Kapelski P, Skibinska M, Maciukiewicz M, Wilkosc M, Frydecka D, Groszewska A, Narozna B, Dmitrzak-Weglarz M, Czerski P, Pawlak J, Rajewska-Rager A, Leszczynska-Rodziewicz A, Slopien A, Zaremba D, Twarowska-Hauser J. Kapelski P, et al. Schizophr Res. 2015 Dec;169(1-3):1-9. doi: 10.1016/j.schres.2015.10.008. Epub 2015 Oct 23. Schizophr Res. 2015. PMID: 26481614

5

Interleukin-6 receptor polymorphism is prevalent in HIV-negative Castleman Disease and is associated with increased soluble interleukin-6 receptor levels.

Stone K, Woods E, Szmania SM, Stephens OW, Garg TK, Barlogie B, Shaughnessy JD Jr, Hall B, Reddy M, Hoering A, Hansen E, van Rhee F. Stone K, et al. PLoS One. 2013;8(1):e54610. doi: 10.1371/journal.pone.0054610. Epub 2013 Jan 23. PLoS One. 2013. PMID: 23372742 Free PMC article.

6

Strong association of interleukin-6 -174G/C promoter single nucleotide polymorphism with a decreased risk of colorectal cancer in ethnic Kashmiri population: A case control study.

Banday MZ, Balkhi HM, Sameer AS, Chowdri NA, Haq E. Banday MZ, et al. Tumour Biol. 2017 Mar;39(3):1010428317695940. doi: 10.1177/1010428317695940. Tumour Biol. 2017. PMID: 28349833 Free article.

7

Impact of interleukin-6 -174 G>C gene promoter polymorphism on neuroblastoma.

Totaro F, Cimmino F, Pignataro P, Acierno G, De Mariano M, Longo L, Tonini GP, Iolascon A, Capasso M. Totaro F, et al. PLoS One. 2013 Oct 21;8(10):e76810. doi: 10.1371/journal.pone.0076810. eCollection 2013. PLoS One. 2013. PMID: 24204677 Free PMC article.

8

Association of Genetic Polymorphisms and Serum Levels of IL-6 and IL-8 with the Prognosis in Children with Neuroblastoma.

Moreno-Guerrero SS, Ramírez-Pacheco A, Rocha-Ramírez LM, Hernández-Pliego G, Eguía-Aguilar P, Escobar-Sánchez MA, Reyes-López A, Juárez-Villegas LE, Sienra-Monge JJL. Moreno-Guerrero SS, et al. Cancers (Basel). 2021 Jan 30;13(3):529. doi: 10.3390/cancers13030529. Cancers (Basel). 2021. PMID: 33573284 Free PMC article.

9

Beta-Lapachone Attenuates BMSC-Mediated Neuroblastoma Malignant Transformation by Inhibiting Gal-3/Gal-3BP/IL6 Axis.

Zhou Y, Yan H, Zhou Q, Feng R, Wang P, Yang F, Zhang Y, Yuan Z, Zhai B. Zhou Y, et al. Front Pharmacol. 2021 Nov 1;12:766909. doi: 10.3389/fphar.2021.766909. eCollection 2021. Front Pharmacol. 2021. PMID: 34790130 Free PMC article.

10

Phase II study of personalized peptide vaccination for previously treated advanced colorectal cancer.

Kibe S, Yutani S, Motoyama S, Nomura T, Tanaka N, Kawahara A, Yamaguchi T, Matsueda S, Komatsu N, Miura M, Hinai Y, Hattori S, Yamada A, Kage M, Itoh K, Akagi Y, Sasada T. Kibe S, et al. Cancer Immunol Res. 2014 Dec;2(12):1154-62. doi: 10.1158/2326-6066.CIR-14-0035. Epub 2014 Oct 28. Cancer Immunol Res. 2014. PMID: 25351849 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

32 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year